These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7954282)
21. Who pays for clinical research? Weiss GB Clin Res; 1979 Oct; 27(4):297-9. PubMed ID: 10309043 [No Abstract] [Full Text] [Related]
22. Payment reform. The lynchpin of health care reform. Sonier JJ; Blewett LA Minn Med; 2011 Feb; 94(2):33-7. PubMed ID: 21462664 [TBL] [Abstract][Full Text] [Related]
23. Financing of clinical trials. van den Noort S Arch Neurol; 1983 Oct; 40(11):697-9. PubMed ID: 6625977 [No Abstract] [Full Text] [Related]
27. Patient care cancer clinical trials at the National Cancer Institute: a resource for payers and providers. Pearson D Manag Care Q; 2002; 10(1):33-7. PubMed ID: 15988953 [TBL] [Abstract][Full Text] [Related]
28. Barriers to clinical trial enrollment: are state mandates the solution? Hillner BE J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958 [No Abstract] [Full Text] [Related]
29. Health care policies affecting the treatment of patients with cancer and cancer research. Mortenson LE Cancer; 1994 Oct; 74(7 Suppl):2204-7. PubMed ID: 8087793 [TBL] [Abstract][Full Text] [Related]
30. The impact of health care reform on reimbursement for investigational therapy. Turner S Cancer Invest; 1993; 11(1):68-9. PubMed ID: 8422599 [No Abstract] [Full Text] [Related]
31. Ethical and financial considerations in third-party support of investigational cancer therapies. Young FE Cancer; 1993 Nov; 72(9 Suppl):2854-8. PubMed ID: 8402519 [TBL] [Abstract][Full Text] [Related]
32. Payer coverage for patients enrolled onto clinical trials: making the process easy and transparent for everyone. Palackdharry CS; Evans DL; McDonough RS; Clarke ME; Cross JD; Klein IM; Reisman L Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP91-7. PubMed ID: 22693988 [No Abstract] [Full Text] [Related]
33. Dissemination of information on legislative mandates and consensus-based programs addressing payment of the costs of routine care in clinical trials through the World Wide Web. Monaco V Cancer; 2004 Dec; 101(11):2709-10; author reply 2710. PubMed ID: 15382087 [No Abstract] [Full Text] [Related]
34. Current issues in pharmaceutical reimbursement. Fijalka S; Fye D; Johnson PE Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S11-26. PubMed ID: 18192243 [TBL] [Abstract][Full Text] [Related]
35. The impact of clinical trial protocols on patient care in a community hospital. McKenna RJ Cancer; 1993 Nov; 72(9 Suppl):2828-33. PubMed ID: 8402513 [TBL] [Abstract][Full Text] [Related]
36. Beware the Medical-Industrial Complex. Stevens CW; Glatstein E Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005 [TBL] [Abstract][Full Text] [Related]
38. Arguing over money. Reform debate turns to costs, reimbursement cuts. DoBias M Mod Healthc; 2009 Jun; 39(25):8-10. PubMed ID: 19582905 [No Abstract] [Full Text] [Related]
39. Paying for patient care in treatment research--who is responsible? Wittes RE Cancer Treat Rep; 1987 Feb; 71(2):107-13. PubMed ID: 3100033 [No Abstract] [Full Text] [Related]
40. Letter to the editors: response to payer coverage for patients enrolled onto clinical trials. Wong YN; Ward J; Neuss M Am J Manag Care; 2012 Nov; 18(11):e438. PubMed ID: 23198753 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]